Semaglutide denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Semaglutide

UnitedHealthcare routinely places semaglutide on a tier or formulary classification that triggers mandatory prior authorization (PA) before the plan will cover fills. A "prior-auth-required" denial means the prescription was dispensed or submitted without an approved PA on file — not necessarily that you don't qualify, just that the administrative gate was not cleared first.

This is one of the most commonly reversed denial types because the underlying clinical criteria are often met; the barrier is procedural, not clinical.

## Federal Appeal Framework

• Internal appeal — you or your prescriber should file immediately. For ERISA-governed plans, the plan must decide within 15 days for pre-service urgent care appeals and 30 days for standard pre-service appeals.
• Concurrent or retroactive PA — in many cases, submitting the PA documentation after the fact while the appeal is pending resolves the denial without requiring a full formal appeal hearing.
• External review (ACA §2719) — if the plan denies your internal appeal, an independent external review is available. The external-review window is generally within approximately four months of the original adverse determination. Expedited review is available for urgent situations.

## Documentation to Gather

• UnitedHealthcare's current published PA criteria for semaglutide — download this from UHC's provider or member portal. Every criterion listed must be addressed in your submission.
• Prescriber letter of medical necessity — should state the diagnosis, why semaglutide is appropriate, the FDA-approved indication being treated, and how the patient's clinical profile meets each PA criterion.
• Diagnosis confirmation — office notes, lab work, or specialist records confirming the condition being treated, documented with dates.
• Prior-treatment history — dated records of earlier medications or interventions tried, with documented outcomes or reasons for discontinuation.
• Clinical severity documentation — chart notes reflecting the clinical picture (symptoms, comorbidities, relevant lab trends) at the time of prescribing.

## Criteria-Mapping Structure

Match each UHC PA requirement to a specific chart fact:

| UHC PA Criterion | Supporting Chart Evidence | |---|---| | Confirmed diagnosis | [Diagnosis + date from chart] | | Prior therapy attempted | [Drug name, dates, outcome] | | Prescribing provider type/specialty | [Provider credentials] | | Any additional plan-specific criterion | [Corresponding chart fact] |

## Key Argument

PA denials on procedural grounds are reversible when the clinical record demonstrates that the substantive criteria were met at the time of prescribing. Frame your appeal as: "The PA was not on file at the time of dispensing, but the patient met every clinical criterion. We are providing that documentation now and request approval retroactively." Attach the criteria-mapping table and all supporting records.